USF Genomics & College of Public Health, University of South Florida, Tampa, FL 33612, USA.
Emma Willard School, Troy, NY 12180, USA.
Cells. 2021 Dec 11;10(12):3504. doi: 10.3390/cells10123504.
The SARS-CoV-2 (COVID-19) pandemic has caused millions of deaths worldwide. Early risk assessment of COVID-19 cases can help direct early treatment measures that have been shown to improve the prognosis of severe cases. Currently, circulating miRNAs have not been evaluated as canonical COVID-19 biomarkers, and identifying biomarkers that have a causal relationship with COVID-19 is imperative. To bridge these gaps, we aim to examine the causal effects of miRNAs on COVID-19 severity in this study using two-sample Mendelian randomization approaches. Multiple studies with available GWAS summary statistics data were retrieved. Using circulating miRNA expression data as exposure, and severe COVID-19 cases as outcomes, we identified ten unique miRNAs that showed causality across three phenotype groups of COVID-19. Using expression data from an independent study, we validated and identified two high-confidence miRNAs, namely, hsa-miR-30a-3p and hsa-miR-139-5p, which have putative causal effects on developing cases of severe COVID-19. Using existing literature and publicly available databases, the potential causative roles of these miRNAs were investigated. This study provides a novel way of utilizing miRNA eQTL data to help us identify potential miRNA biomarkers to make better and early diagnoses and risk assessments of severe COVID-19 cases.
SARS-CoV-2(COVID-19)大流行已在全球范围内造成数百万人死亡。对 COVID-19 病例进行早期风险评估有助于指导早期治疗措施,这些措施已被证明可以改善重症病例的预后。目前,循环 miRNA 尚未被评估为经典的 COVID-19 生物标志物,确定与 COVID-19 具有因果关系的生物标志物至关重要。为了弥补这些空白,我们旨在使用两样本 Mendelian 随机化方法研究 miRNA 对 COVID-19 严重程度的因果影响。我们检索了多项具有可用 GWAS 汇总统计数据的研究。使用循环 miRNA 表达数据作为暴露因素,严重 COVID-19 病例作为结局,我们在 COVID-19 的三个表型组中鉴定出了十种具有因果关系的独特 miRNA。使用来自独立研究的表达数据,我们验证并确定了两个高可信度的 miRNA,即 hsa-miR-30a-3p 和 hsa-miR-139-5p,它们对严重 COVID-19 病例的发展具有潜在的因果作用。利用现有文献和公开可用的数据库,研究了这些 miRNA 的潜在因果作用。本研究提供了一种利用 miRNA eQTL 数据的新方法,有助于我们确定潜在的 miRNA 生物标志物,从而对严重 COVID-19 病例进行更好和更早的诊断和风险评估。